Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ELV · Entity 2934 | EVP & Pres Carelon & CarelonRx | March 02, 2026 | March 04, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date March 02, 2026 · Filed March 04, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 27,222 |
Ending reported balance
After 2026-03-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-03-02 · Tax withholding · Disposed 1,201 · Balance 24,803 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Row 2 · 2026-03-02 · Grant · Acquired 2,865 · Balance 27,668 F2: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026. Row 3 · 2026-03-03 · Tax withholding · Disposed 446 · Balance 27,222 F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. |
Filing footnotes · ownership attribution and instrument terms
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 22, 2021 Filed Mar 23, 2021 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 15,593 | $146.93 | $2,291,079.49 |
DisclosureSEC source: 0001156039-21-000038 · wf-form4_161653145347931.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 492 | $311.66 | $153,336.72 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,951 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,533 | $0.00 Strike: $311.48 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,533 Underlying: Common Stock · 11,533 shares Expires 2031-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,533 shares, and is exercisable in three annual installments, with two installments of 3,844 shares each and one installment of 3,845 shares, beginning on 3/1/2022, which is the one-year anniversary of the option grant date. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 23,222 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,443 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/1/2021. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,221 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 936 shares on 3/1/2022, and 937 shares each on 3/1/2023 and 3/1/2024. Read SEC document |
| March 01, 2021 Filed Mar 3, 2021 21:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 14,231 | $311.48 | $4,432,671.88 |
DisclosureSEC source: 0001156039-21-000023 · wf-form4_161480704164761.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,411 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,833 | $0.00 Strike: $146.93 | $0.00 |
DisclosureSEC source: 0001156039-20-000105 · wf-form4_160824083142314.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,593 Underlying: Common Stock · 5,833 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option represents a right to purchase a total of 22,353 shares, and is exercisable in six semi-annual installments with three installment of 3,725 shares and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 100 | $313.42 | $31,342.00 |
DisclosureSEC source: 0001156039-20-000105 · wf-form4_160824083142314.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,642 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 3,836 | $312.76 | $1,199,747.36 |
DisclosureSEC source: 0001156039-20-000105 · wf-form4_160824083142314.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,742 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $312.30 to $313.11. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,897 | $312.01 | $591,882.97 |
DisclosureSEC source: 0001156039-20-000105 · wf-form4_160824083142314.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,578 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August, 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $311.26 to $312.22. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 21:34 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 5,833 | $146.93 | $857,042.69 |
DisclosureSEC source: 0001156039-20-000105 · wf-form4_160824083142314.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,475 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 927 | $0.00 Strike: $146.93 | $0.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · derivative · entry 11 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,426 Underlying: Common Stock · 927 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The option represents a right to purchase a total of 22,353 shares, and is exercisable in six semi-annual installments with three installments of 3,725 shares each and three installments of 3,726 shares each beginning on September 2, 2015, which is the six-month anniversary of the option grant date. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 781 | $0.00 Strike: $100.77 | $0.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · derivative · entry 10 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 781 shares Expires 2021-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 300 | $337.00 | $101,100.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 9 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,642 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 675 | $335.92 | $226,746.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 8 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,942 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F7 · price: This transaction was executed in multiple trades at prices ranging from $335.91 to $335.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,193 | $334.87 | $399,499.91 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 7 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,617 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $334.77 to $334.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,200 | $333.97 | $400,764.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 6 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,810 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $333.72 to $334.57. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,056 | $332.86 | $351,500.16 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,010 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $332.54 to $333.16. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 400 | $331.92 | $132,768.00 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,066 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $331.44 to $332.27. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,010 | $330.77 | $334,077.70 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,466 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $330.31 to $331.04. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 927 | $146.93 | $136,204.11 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,476 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 21:32 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 781 | $100.77 | $78,701.37 |
DisclosureSEC source: 0001156039-20-000095 · wf-form4_160573513891253.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,549 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,667 | $0.00 Strike: $100.77 | $0.00 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · derivative · entry 8 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 781 Underlying: Common Stock · 4,667 shares Expires 2021-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,167 | $295.00 | $344,265.00 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 7 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,768 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 147 | $293.98 | $43,215.06 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 6 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,935 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F6 · price: This transaction was executed in multiple trades at prices ranging from $293.87 to $294.04. The price reported reflects the weighted average sale price. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,120 | $293.33 | $328,529.60 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,082 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $292.75 to $293.64. The price reported reflects the weighted average sale price. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,600 | $292.13 | $467,408.00 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,202 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $291.71 to $292.62. The price reported reflects the weighted average sale price. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 800 | $290.30 | $232,240.00 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,802 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $289.81 to $290.79. The price reported reflects the weighted average sale price. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,000 | $287.58 | $287,580.00 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,602 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $287.17 to $287.90. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (6) to this Form 4. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 4,667 | $100.77 | $470,293.59 |
DisclosureSEC source: 0001156039-20-000086 · wf-form4_160313949706885.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,602 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 20:31 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,167 | $295.00 | $344,265.00 |
DisclosureSEC source: 0001156039-20-000084 · wf-form4_160262106970413.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,935 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $295.00 to $295.07. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,592 | $0.00 Strike: $100.77 | $0.00 |
DisclosureSEC source: 0001156039-20-000081 · wf-form4_160201623389996.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,448 Underlying: Common Stock · 2,592 shares Expires 2021-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,075 | $0.00 Strike: $89.44 | $0.00 |
DisclosureSEC source: 0001156039-20-000081 · wf-form4_160201623389996.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,075 shares Expires 2021-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 11,409 shares, and is exercisable in six semi-annual installments with three installments of 1,901 shares each and three installments of 1,902 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,667 | $280.00 | $1,306,760.00 |
DisclosureSEC source: 0001156039-20-000081 · wf-form4_160201623389996.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,102 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2020. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,592 | $100.77 | $261,195.84 |
DisclosureSEC source: 0001156039-20-000081 · wf-form4_160201623389996.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2020 Filed Oct 6, 2020 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,075 | $89.44 | $185,588.00 |
DisclosureSEC source: 0001156039-20-000081 · wf-form4_160201623389996.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,334 | $0.00 Strike: $89.44 | $0.00 |
DisclosureSEC source: 0001156039-20-000059 · wf-form4_159182121303810.xml · derivative · entry 5 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075 Underlying: Common Stock · 9,334 shares Expires 2021-03-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 11,409 shares, and is exercisable in six semi-annual installments with three installments of 1,901 shares and three installments of 1,902 shares each beginning on September 3, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,087 | $0.00 Strike: $100.77 | $0.00 |
DisclosureSEC source: 0001156039-20-000059 · wf-form4_159182121303810.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,040 Underlying: Common Stock · 2,087 shares Expires 2021-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 10,127 shares, and is exercisable in six semi-annual installments with one installment of 1,687 shares and five installments of 1,688 shares each beginning on November 1, 2014, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 14,001 | $300.00 | $4,200,300.00 |
DisclosureSEC source: 0001156039-20-000059 · wf-form4_159182121303810.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,102 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 25, 2020. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 9,334 | $89.44 | $834,832.96 |
DisclosureSEC source: 0001156039-20-000059 · wf-form4_159182121303810.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,103 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 08, 2020 Filed Jun 10, 2020 20:33 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 2,087 | $100.77 | $210,306.99 |
DisclosureSEC source: 0001156039-20-000059 · wf-form4_159182121303810.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,769 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,926 | $0.00 Strike: $271.27 | $0.00 |
DisclosureSEC source: 0001127602-20-009435 · form4.xml · derivative · entry 4 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,926 Underlying: Common Stock · 15,926 shares Expires 2030-03-02 F4 · derivative.exercise_date: The option represents a right to purchase a total of 15,926 shares, and is exercisable in three annual installments, with one installment of 5,308 shares and two installments of 5,309 shares each, beginning on 3/2/2021, which is the one-year anniversary of the option grant date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 37,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009435 · form4.xml · nonDerivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,682 F3 · shares: Represents performance based restricted share units. Restrictions lapse on 3/2/2020. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,996 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-009435 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,262 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 998 shares on 3/2/2021, and 999 shares each on 3/2/2022 and 3/2/2023. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 21:39 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 19,683 | $271.27 | $5,339,407.41 |
DisclosureSEC source: 0001127602-20-009435 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| December 24, 2019 Filed Dec 26, 2019 19:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,166 | $303.82 | $1,265,714.12 |
DisclosureSEC source: 0001127602-19-035835 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,949 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 19:42 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 4,167 | $303.32 | $1,263,934.44 |
DisclosureSEC source: 0001127602-19-035835 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,115 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:04 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 3,762 | $0.00 Strike: $61.88 | $0.00 |
DisclosureSEC source: 0001127602-19-033441 · form4.xml · derivative · entry 3 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,762 shares Expires 2020-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option represents a right to purchase a total of 7,523 shares, and is exercisable in six semi-annual installments, with one installment of 1,253 shares and five installments of 1,254 shares each, beginning on September 1, 2013, which is the six-month anniversary of the option grant date. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:04 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 12,095 | $300.00 | $3,628,500.00 |
DisclosureSEC source: 0001127602-19-033441 · form4.xml · nonDerivative · entry 2 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,282 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 25, 2019. Read SEC document |
| November 18, 2019 Filed Nov 21, 2019 00:04 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,762 | $61.88 | $232,792.56 |
DisclosureSEC source: 0001127602-19-033441 · form4.xml · nonDerivative · entry 1 Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,377 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.